Type: Public
On the web: http://www.frx.com
Employees: 5,600
Employee growth: 7.7%

Forest Laboratories doesn't just blend in with the trees. The company develops and manufactures name-brand as well as generic prescription and over-the-counter pharmaceutical products. The company's central nervous system (CNS) pharmaceutical line includes antidepressants Celexa and Lexapro, as well as Namenda, which treats Alzheimer's disease. Other products include treatments for hypertension, thyroid disease, respiratory ailments, and pain. Forest Laboratories markets directly to doctors, hospitals, drugstore chains, managed care organizations, and distributors through its own sales force in the US; it also has affiliated and independent sales representatives in the UK and Ireland.

Key numbers for fiscal year ending December, 2011:
Sales: $4,419.7M
One year growth: 5.4%
Net income: $1,046.8M
Income growth: 53.4%

Officers:
Chairman, President, and CEO: Howard Solomon
EVP Finance and Administration and CFO: Francis I. (Frank) Perier Jr.
SVP Sales: Jerome Lynch

Competitors:
Eli Lilly
GlaxoSmithKline
Pfizer

© 2012 Hoover's, Inc. All rights reserved.